NasdaqCM - Delayed Quote • USD
Pulmatrix, Inc. (PULM)
At close: April 25 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -1.04 | 0 | -4.34 | -4.5 |
Low Estimate | -1.04 | 0 | -4.34 | -4.5 |
High Estimate | -1.04 | 0 | -4.34 | -4.5 |
Year Ago EPS | -1.45 | -1.14 | -5.46 | -4.34 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | 2.2M | -- | 7.3M | 6.93M |
Low Estimate | 1.77M | -- | 6.87M | 6.93M |
High Estimate | 1.77M | -- | 6.87M | 6.93M |
Year Ago Sales | 1.71M | -- | 6.07M | 7.3M |
Sales Growth (year/est) | 28.90% | -- | 20.20% | -5.00% |
Earnings History
CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 6/30/2023 | 9/30/2023 |
---|---|---|---|---|
EPS Est. | -1.51 | -1.44 | -1.23 | -1.05 |
EPS Actual | -1.45 | -1.14 | -1.04 | -1.03 |
Difference | 0.06 | 0.3 | 0.19 | 0.02 |
Surprise % | 4.00% | 20.80% | 15.40% | 1.90% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Current Estimate | -1.04 | 0 | -4.34 | -4.5 |
7 Days Ago | -1.04 | 0 | -4.34 | -4.5 |
30 Days Ago | -1.04 | 0 | -4.34 | -4.5 |
60 Days Ago | -1.04 | 0 | -4.34 | -4.5 |
90 Days Ago | -1.04 | 0 | -4.34 | -4.5 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | PULM | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 28.30% | -- | -- | 2.60% |
Next Qtr. | -- | -- | -- | 13.40% |
Current Year | 20.50% | -- | -- | 5.20% |
Next Year | -3.70% | -- | -- | 13.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.11% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2023 |
Reiterates | HC Wainwright & Co.: Buy | 2/7/2023 |
Maintains | HC Wainwright & Co.: Buy | 3/30/2022 |
Related Tickers
SYBX Synlogic, Inc.
1.8600
-1.06%
RPHM Reneo Pharmaceuticals, Inc.
1.6500
-1.79%
PRTC.L PureTech Health plc
212.50
0.00%
GLTO Galecto, Inc.
0.6689
-0.31%
NERV Minerva Neurosciences, Inc.
2.4300
-3.57%
BLPH Bellerophon Therapeutics, Inc.
0.0550
+1.66%
ALVR AlloVir, Inc.
0.8000
+2.56%
PRTC PureTech Health plc
27.33
-5.27%
EIGRQ Eiger BioPharmaceuticals, Inc.
3.0400
-19.95%
GLPG.AS Galapagos NV
26.56
-2.06%